Ramiah Investment Group

Position in GILD — Gilead Sciences, Inc.

CIK 1566307 BROOKFIELD, WI

Position in GILD

as of Jun 30, 2026 · filed Jul 16, 2026 Compact

Position Value

$379,525

New position

Shares Held

3,004

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.81%

of 13F equity value

Holder Rank

#1,526

of 2,266 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Ramiah Investment Group holds $2,594,267 across 6 Drug Manufacturers - General names. GILD ranks #5 (14.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	4,246	$545,611
2	AMGN	Amgen Inc	1,454	$526,522
3	ABBV	AbbVie Inc.	1,865	$469,308
4	BIIB	Biogen Inc.	2,085	$450,485
5	GILD	Gilead Sciences, Inc. This page	3,004	$379,525
6	BMY	Bristol Myers Squibb Co	3,867	$222,816

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$379,525	3,004	—	Shares	Sole	2026-07-16
No filing history on record for this holder in this stock.